AI-enabled protein design company Profluent has launched OpenCRISPR-1, an open-source gene editor designed with artificial intelligence. This new technology can create molecules capable of editing human DNA, demonstrating a significant advancement in genetic engineering.
CRISPR technology, developed over a decade ago, allows precise modification of DNA sequences in living organisms. Potential applications include treatments for genetic disorders and researching disease mechanisms. Unlike previous gene-editing tools like CRISPR-Cas9, the molecules designed by OpenCRISPR-1 are entirely synthetic.
Profluent has made OpenCRISPR-1 freely available for ethical research and commercial use, sharing the science behind its development in a preprint publication.
“Editing human DNA with an AI-designed system was a scientific moonshot,” said Ali Madani, Profluent cofounder and CEO. “Our success points to a future where AI designs bespoke cures for disease.”
So…:
What significance does the release of gene technology have for health development, and what should one be aware of in this development?
Source & Picture: